Levamisole
Back to searchMolecule Structure
Scientific Name
Levamisole
Description of the Drug
Levamisole is levamisole is a nicotinic receptor agonist used to treat helminth infections and some skin infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00848
http://www.drugbank.ca/drugs/DB00848
Brand Name(s)
Not Available
Company Owner(s)
Janssen Pharmaceutica Products Lp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Nicotinic acetylcholine receptor alpha subunit | SINGLE PROTEIN | AGONIST | CHEMBL1884 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL19227 | |
| PharmGKB | PA450205 | |
| Human Metabolome Database | HMDB0014986 | |
| DrugBank | DB00848 | |
| PubChem: Thomson Pharma | 14748767 | 15171780 |
| PubChem | 26879 | |
| Mcule | MCULE-4392506462 | |
| LINCS | LSM-6655 | |
| Nikkaji | J8.518I | |
| BindingDB | 50241179 | |
| EPA CompTox Dashboard | DTXSID4023206 | |
| DrugCentral | 1561 | |
| Brenda | 3477 | |
| Guide to Pharmacology | 7210 | |
| rxnorm | LEVAMISOLE | LEVAMISOLE HYDROCHLORIDE |
| KEGG Ligand | C07070 | |
| ChEBI | 6432 | |
| ZINC | ZINC000000119839 |
